Use of a structured migraine diary improves patient and physician communication about migraine disability and treatment outcomes

被引:25
作者
Baos, V
Ester, F
Castellanos, A
Nocea, G
Caloto, MT
Gerth, WC
机构
[1] Merck & Co Inc, Worldwide Outcomes Res, Whitehouse Stn, NJ 08889 USA
[2] Ctr Salud Collado Villalba, Madrid, Spain
[3] Ctr Atenc Primaria Morell, Tarragona, Spain
[4] Ctr Salud Gerena, Seville, Spain
[5] Outcomes Res, MSD, Madrid, Spain
关键词
migraine; treatment outcomes; disability diary;
D O I
10.1111/j.1742-1241.2005.00469.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Migraine is frequently undertreated, perhaps because impaired communication between patients and physicians underestimate the disability associated with migraine attacks. The purpose of this study was to evaluate the benefits of a structured migraine diary used during a prospective open-label study of triptannaive patients in Spain for recording information on response to therapy for a pre-study migraine attack and three consecutive migraine attacks, the first and third treated with rizatriptan 10-mg wafer and the second with usual non-triptan therapy. Of 97 patients (83% women; mean age, 39 years) who completed the study, all reported moderate to severe pain, and two-thirds reported severe to total impairment during migraine attacks. At study end, 72% of patients reported that the migraine diary helped communication with their doctor about migraine, and 70% were more or much more satisfied than before the study with level of overall medical care provided by their doctor. Patients who reported the diary to be useful also reported higher overall satisfaction with medical care (p < 0.001). Most of the 22 physicians (91%) reported that the diary enabled them to better communicate with their patients about migraine, and all reported that it enabled them to assess differences in pain intensity and disability across patients. We conclude that a structured migraine diary can be a valuable aid for improving communication between physicians and patients regarding migraine disability and treatment outcomes.
引用
收藏
页码:281 / 286
页数:6
相关论文
共 22 条
[1]  
Baos V, 2003, INT J CLIN PRACT, V57, P761
[2]   Efficacy and safety of rizatriptan versus standard care during long-term treatment for migraine [J].
Block, GA ;
Goldstein, J ;
Polis, A ;
Reines, SA ;
Smith, ME .
HEADACHE, 1998, 38 (10) :764-771
[3]   Global trends in migraine care - Results from the MAZE survey [J].
Brandes, JL .
CNS DRUGS, 2002, 16 (Suppl 1) :13-18
[4]  
Cady R, 2001, MedGenMed, V3, P1
[5]   Validation of a migraine work and productivity loss questionnaire for use in migraine studies [J].
Davies, GM ;
Santanello, N ;
Gerth, W ;
Lerner, D ;
Block, GA .
CEPHALALGIA, 1999, 19 (05) :497-502
[6]   New guidelines for the management of migraine in primary care [J].
Dowson, AJ ;
Lipscombe, S ;
Sender, J ;
Rees, T ;
Watson, D .
CURRENT MEDICAL RESEARCH AND OPINION, 2002, 18 (07) :414-439
[7]   Information about migraine disability influences physicians' perceptions of illness severity and treatment needs [J].
Holmes, WF ;
MacGregor, EA ;
Sawyer, JPC ;
Lipton, RB .
HEADACHE, 2001, 41 (04) :343-349
[8]   Survey of migraineurs referred to headache specialists: Care, satisfaction, and outcomes [J].
Hu, XH ;
O'Donnell, F ;
Kunkel, RS ;
Gerard, G ;
Markson, LE ;
Berger, ML .
NEUROLOGY, 2000, 55 (01) :141-143
[9]   Real-world experiences in migraine therapy with rizatriptan [J].
Jamieson, D ;
Cutrer, FM ;
Goldstein, J ;
Dayno, J ;
Hu, XH .
HEADACHE, 2003, 43 (03) :223-230
[10]   Migraine consultation patterns in primary care.: Results from the PCAOM study 1994-96 [J].
Krobot, KJ ;
Schröder-Bernhardi, D ;
Pfaffenrath, V .
CEPHALALGIA, 1999, 19 (09) :831-840